Skip to main content
    M

    Maravai Lifesciences Holdings Inc (MRVI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.28
    -0.12 (-1.62%)

    Market Cap: $1.96B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Maravai Lifesciences Holdings Inc (MRVI) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Maravai Lifesciences Holdings (MRVI) has a latest price of $7.28 on Nov 17, 2026, 22.7% below its 52-week high of $9.42. Its price rose 100.0% over the past 12 months. The month-end price fell 81.5% over the 5 years through Oct 2026, a compound annual decline of 28.7%.

    Price Chart

    From Nov 2020 to Oct 2026, its highest month-end close was $59.18 in Aug 2021 and its lowest $2.02 in Apr 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MRVI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MRVI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 0.8%, and over 6 months it rose 72.5%. The month-end price rose 13.8% over the 3 years through Oct 2026, a compound annual rate of 4.4%.

    PeriodChange
    1 month+4.1%
    3 months+0.8%
    6 months+72.5%
    12 months+100.0%
    12 months, with dividends+100.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+13.8%+4.4%
    5 years-81.5%-28.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 49.4%, and its weakest was 2022, when it fell 65.8%.

    YearCloseChange
    2026 through Oct 2026$7.81+140.3%
    2025$3.25-40.4%
    2024$5.45-16.8%
    2023$6.55-54.2%
    2022$14.31-65.8%
    2021$41.90+49.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 1.6% below its 50-day average of $7.40 and 33.1% above its 200-day average of $5.47.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.28
    52-week high$9.42-22.7%
    52-week low$2.80+160.0%
    50-day average$7.40-1.6%
    200-day average$5.47+33.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 84.8%.

    MeasureValue
    1-year beta1.65
    Largest fall, 1 year-29.6%
    Largest fall, 3 years-84.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MRVI

    What is MRVI's 1-year price change?

    Maravai Lifesciences Holdings's price rose 100.0% over the past 12 months. With dividends included, the 12-month total return was 100.0%.

    What is MRVI's 5-year price change?

    Maravai Lifesciences Holdings's month-end price fell 81.5% over the 5 years through Oct 2026, a compound annual decline of 28.7%. These figures leave out dividends.

    What is MRVI's 52-week high and low?

    Maravai Lifesciences Holdings's 52-week high is $9.42 and its 52-week low is $2.80. Its latest price of $7.28 on Nov 17, 2026 is 22.7% below the high.

    What is MRVI's beta?

    Maravai Lifesciences Holdings's 1-year beta against the S&P 500 is 1.65, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 29.6%.

    Is the MRVI chart free?

    Yes. Advanced Charting for MRVI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.